News

Copenhagen, Denmark, December 21, 2015 – – Vipergen ApS, a biotechnology company focused on small molecule drug discovery using its proprietary 2 nd generation DNA-encoded library platform, today announced the initiation of a drug discovery collaboration with Actelion Pharmaceuticals Ltd (a subsidiary of Actelion Ltd, SIX: ATLN), a leading biopharmaceutical company focused on the discovery, […]

Copenhagen, Denmark, December 18 2015 – – Vipergen ApS, a biotechnology company focused on small molecule drug discovery using its proprietary 2nd generation DNA-encoded library platform, today announced the signing of a drug discovery agreement with Amgen Inc., a global leader in the biotech industry. Under the terms of the agreement, Vipergen’s small molecule discovery